Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05268055 · ClinicalTrials.gov registry record · NA
Sign Here: How to Conduct Informed Consent With Deaf Individuals
A NA study of Cultural Competency, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT05268055: Completed NA study of Cultural Competency, sponsored by University of Massachusetts, Worcester.
NCT05268055 is a NA study of Cultural Competency that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 208 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05268055, a NA study of Cultural Competency, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research is to create a training film for hearing healthcare providers to teach them how to competently and sensitively interact with Deaf patients. In Year 1, focus groups will be facilitated to elicit feedback that will inform video production of the training film. In Year 2, film production will take place, as well as a randomized clinical trial (RCT) to test the feasibility and preliminary efficacy of the new training intervention.
Primary Outcome
A validated scale used to measure provider cultural competence. Total scores range from 9 to 63, with higher scores indicative of higher levels of cultural competency.
Conditions Studied
Interventions
- OTHER "Sign Here" training intervention
- OTHER Intervention as usual
Study Locations (1)
Massachusetts
- University of Massachusetts Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2023-05-03 |
| Est. Completion | 2023-10-01 |
| Phase | NA |
What the finished NCT05268055 record still lists
NCT05268055 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Cultural Competency appearing as the primary indexed condition, and to 2 interventions - of which "Sign Here" training intervention is the first listed.
NCT05268055 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05268055 about?
NCT05268055 is a clinical study titled "Sign Here: How to Conduct Informed Consent With Deaf Individuals". The goal of this research is to create a training film for hearing healthcare providers to teach them how to competently and sensitively interact with Deaf patients. In Year 1, focus groups will be facilitated to elicit feedback that will inform video production of the training film. In Year 2, film...
What is the current status of trial NCT05268055?
This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2023-05-03. Estimated completion is 2023-10-01.
What conditions does trial NCT05268055 study?
This clinical trial studies the following conditions: Cultural Competency.
What interventions are being tested in trial NCT05268055?
The interventions under investigation include: "Sign Here" training intervention (OTHER), Intervention as usual (OTHER).
Who is sponsoring clinical trial NCT05268055?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05268055 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05268055's enrollment target sits among peer trials
208 496th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI